Тикагрелор при остром коронарном синдроме: повышение эффективности и безопасности лечения

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–504.
2. Thom T, Haase N, Rosamond W et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: 85–151.
3. Kei AA, Florentin M et al. Antiplatelet Drugs: What comes next? Clin Applied Thrombosis Hemostasis 2011; 17 (1): 9–26.
4. Wiviotti SD, Braunwald E et al. for the TRITON-TIMI 38 Investigators. Prasugrel vs. clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001–15.
5. Roe MT, Armstrong PW, Fox KA et al. Trilogy ACS Investigators. Prasugrel vs. clopidogrel for the acute coronary syndromes without revascularization. N Engl J Med 2012; 367 (4): 1297–309.
6. Wallentin L, Becker RC, Budaj A et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361 (11): 1045–57.
7. Cannon CP, Harrington RA, James S et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010; 375 (9711): 283–93.
8. Held C, Asenblad N, Bassand JP et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery, results from the PLATO. J Am College Cardiology 2011; 57: 672–84.
9. James SK, Roe MT, Cannon CP et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomized PLATelet inhibition and patient Outcomes (PLATO). Trial Br Med J 2011; 342: 3527.
10. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation. The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation of the European Society of Cardiology. Eur Heart J 2011; 32: 2999–3054.
11. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation. The Task Force on the management of ST segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2012; 33: 2569–619.
12. Levine GN et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am College Cardiology 2011; 58 (24): e44–122.
13. Jneid H, Anderson JL, Wright RS et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non ST elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update). Circulation 2012; 126: 875–910.
14. O’Gara PT, Kushner FG, Ascheim DD et al. 2013 ACCF/AHA Guideline for the management of patients ST elevation myocardial infarction. J Am College Cardiology 2013; 61: 78–140.

П.С.Лагута

Институт клинической кардиологии им. А.Л.Мясникова ФГБУ РКНПК Минздрава России